Glatt Pharma+Biotech Process & Plant Engineering

Glatt will be attending the ISPE Pharma 4.0™ Conference 2025. A special highlight: The presentation on “Implementation of a Highly-automated OSD Production Plant” on December 9 at 1:45 pm, in which Anton Kopitzsch and Pascal Neumann (Bayer) will outline the joint project between us and Bayer – representing a groundbreaking step toward digital transformation and automation in pharmaceutical production.

Lecture by Dirk Steinhäuser, Glatt Ingenieutechnik, at POWTECH TECHNOPHARM - VIRTUAL TALK "Modulare Anlagen", May 13, 2025. The presentation will give an overview on a fast and flexible design approach by Glatt’s Engineering division for both chemical and biotech API / Drug Substance (DS) plants as well manufacturing plants for final dosage forms (FDF) / Drug Products (DP). Pre-designed and proven plant modules, layout typicals and facility structures are applied to accomplish rapid and ‘first-time-right’ plant conceptualization. The modular approach for both process and facility will be outlined with the help of visual examples for the different modular levels and project objectives.

How can you produce 1.2 billion tablets a year faster, more sustainably, and more efficiently than ever before? Bayer provides the answer with its new Solida-1 facility. The “learning factory” sets new standards in automation, AI use, and modularity. But that's not the only reason why the plant is considered a model for the future of pharmaceutical production.

Glatt Process & Plant Engineering expertise in the fields of automation, robotics and system integration. Meet us at booth no. 20! Our process automation experts Anton Kopitzsch and Thomas Geier from Glatt Process & Plant Engineering Pharma+Biotech will explain how Glatt has already implemented store floor automation projects and solutions and what tools are available for setting up or optimizing modern pharmaceutical productions.

Design & Implementation of a new flexible (modular) ATMP production facility. Lecture by Dirk Steinhauser, Glatt Ingenieurtechnik. The case study will provide an overview on the project development from initiation phase, via Concept Design and all Engineering phases, fast-track modular building construction, implementation of HVAC, cleanrooms, biotech equipment for upstream and downstream processing, media and buffer systems and further necessary periphery. Specific requirements for a multi-purpose vaccine production facility will be outlined.

Straubing/Germany, December 2023 – Weimar based Glatt Ingenieurtechnik GmbH will be responsible for the Detail engineering and delivery of integrated process technology for the multipurpose BioCampus MultiPilot (BMP) demonstration facility in the port of Straubing-Sand. The flexible platform, to be used to scale-up and commercialise innovative biotech processes and sustainable products, will enable start-ups, research groups and industrial companies to further develop, test scale up and optimise their biotechnological processes to pre-industrial scale, validate their economic viability and produce material samples.

Dr Reinhard Böber is leaving the management of Glatt Ingenieurtechnik GmbH on 1 September to begin his well-earned retirement. He co-founded the company 32 years ago with the "Continuous Fluidised Bed" research group of the Magdeburg Heavy Engineering Combine (SKET) in Weimar and was largely responsible for the company's development. Dr Böber's farewell ceremony was attended by shareholders, executives and partners of the Glatt Group, as well as numerous representatives from Thuringia's business community, society and politics.

Both spray drying and fluid bed spray granulation can be used to convert liquid products into bulk materials. The most effective process will often be dictated by the desired properties of the final particles and the specific application. Glatt Ingenieurtechnik has a thorough understanding of both techniques and has a long history of designing fluid bed systems that are tailored to individual customer products.

August 2022 – National Science and Technology Development Agency Thailand (NSTDA) is implementing the Government initiative Thailand 4.0 with regard to strategic biotechnology growth hub at Eastern Economic Corridor of Innovation (EECi) in Thailand. One part of the new BIOPOLIS complex is the GMP Biorefinery Pilot Plant at EECi, for which German engineering company Glatt Ingenieurtechnik was selected to provide the engineering services. The contract between NSTDA and Glatt comprises Conceptual and Basic Design phase for the GMP Biorefinery.

February 2022 – Glatt to inaugurate vaccine production in Ghana with fill & finish plant. The facility will serve as a blueprint to establish local vaccine production and is part of the government's Vaccine Development and Manufacturing Presidential Committee (VMC) strategy. Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) has commissioned Glatt Ingenieurtechnik for phase 1 of the project.

The concept of continuous production is captivating. No longer batch by batch - instead, for example, a liquid product can simply be tapped at any time. It is therefore surprising that "continuous manufacturing" did not already triumphantly conquer chemical and pharmaceutical production five or ten years ago. In the meantime, however, there are a whole series of forward-looking examples.

Glatt has expanded its range of services and capacities at the company’s Technology Centre in Weimar for trials and sample development. A new fluid bed granulator and coater for innovative solvent-based processes has recently become available. In addition to the capacity expansion, the existing plant can also now accommodate continuous spray granulation processes.

From core to shell: How modular planning brings flexibility to pharmaceutical production. The principle of modular pharmaceutical production facilities requires a process-oriented, far-sighted approach right from the early planning phase. The experts from Glatt's Process & Plant Engineering division know why this is essential for flexible pharmaceutical solids production.

November 2015: Glatt Ingenieurtechnik GmbH opens a new pharmaceutical engineering branch in Dresden in January 2016. The Glatt Process & Plant Engineering division is thus strengthening its expertise in the fields of pharmaceuticals, biotechnology and active ingredient plants at the Glatt Group's existing site. Among others, a number of experienced pharmaceutical specialists from a major plant engineering company have been recruited for this purpose.